Answer
Third-trimester exposure to Denzapine (clozapine) can cause neonatal extrapyramidal and/or withdrawal symptoms of varying severity and duration after delivery, including agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress or feeding disorder, so newborns should be monitored carefully.
Sources for this answer
- Denzapine 25mg TabletsBritannia Pharmaceuticals Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 13Document updated
Sources checked